Actively Recruiting
Improving Outpatient Endometrial Biopsy Results
Led by Cairo University · Updated on 2024-12-04
400
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
Sponsors
C
Cairo University
Lead Sponsor
A
Al Adan Hospital Kuwait
Collaborating Sponsor
AI-Summary
What this Trial Is About
Pipelle is the most commonly used outpatient endometrial biopsy device. Pipelle endometrial biopsy can diagnose 90% of endometrial cancer cases. Pipelle endometrial biopsy is one of the first-line diagnostic procedures for women presenting with abnormal peri- and post-menopausal vaginal bleeding. Insufficient samples are obtained in 5-23% of cases. In Adan Hospital, a retrospective analysis of all outpatient endometrial samples sent to the histopathology department from April- to October 2024 study showed an insufficient sample percentage of 32% This may be attributed to factors such as patients, equipment, and physicians. This project aims to improve the endometrial biopsy results by Identifying these factors in the Adan hospital setting, Implementing measures to modify these factors, and finally re-auditing the endometrial biopsy results after six months.
CONDITIONS
Official Title
Improving Outpatient Endometrial Biopsy Results
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing outpatient endometrial biopsy between November 2024 and April 2025
You will not qualify if you...
- Unable to obtain sample due to physical issues, anxiety, cervical stenosis, or severe bleeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Adan hospital
Kuwait, Al Ahmadi, Kuwait, 47000
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here